The Ensign Group, Inc.

ENSG Healthcare Medical Care Facilities

The Ensign Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 18.7% from fiscal 2024.

Revenue
+14.5%
EPS
+23.6%
Free cash flow
+89.2%
Total debt
+39.2%

Quarter to September 2026, against a year earlier

182.39 5.92 −3.14%
Market cap
$10.6B
P/E
26.3×
Fwd P/E
25.4×
Dividend yield
0.14%
F-score
7/9
Altman Z
3.57
Beneish M
−2.57
Dividend safety
92/100
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
P/E ratio
24.87 24.40 31.83 28.99

+8 more quarters

P/S ratio
1.75 1.69 2.21 1.97
P/FCF ratio
19.50 22.17 28.67 26.93
P/Operating CF
41.40 54.03 116.23 54.46
P/B ratio
3.88 3.80 4.91 4.47
EV/Sales
1.72 1.66 2.12 1.89
EV/EBITDA
15.46 15.63 20.02 18.00
EV/FCF
19.13 21.74 27.55 25.77
Current Ratio
1.20 1.21 1.56 1.42
Net Debt/EBITDA
(1.13) (1.17) (2.95) (2.84)
Debt/Equity
0.08 0.06 0.06 0.06
Earnings Yield
4.02% 4.10% 3.14% 3.45%
Free Cash Flow Yield
5.13% 4.51% 3.49% 3.71%
Free Cash Flow per Share
3.33 2.06 1.12 2.33
Book value per Share
44.33 42.19 41.02 39.00
Free Cash Flow
192.63 119.13 64.68 133.48
EV/EBIT
19.15 19.49 24.93 22.46
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026